Peter Sandercock

发表

Perfusion image processing

Joanna M. Wardlaw, Trevor K. Carpenter, Eleni Sakka, 2014 .

Points: Is “Lesson of the Week” really a lesson?

Peter Sandercock, 1987 .

The Challenges of Developing a Collaborative Data and Compute Grid for Neurosciences

Andrew C. Simpson, Nick C. Fox, Martin Rossor, 2006, 19th IEEE Symposium on Computer-Based Medical Systems (CBMS'06).

Writing a thesis on a word processor

Peter Sandercock, P. Sandercock, 1984 .

Developing an Integrated Image Bank and Metadata for Large-scale Research in Cerebrovascular Disease: Our Experience from the Stroke Image Bank Project

Joanna M. Wardlaw, Jeb Palmer, Peter Sandercock, 2016, Front. ICT.

Designing for e-Health

Nick C. Fox, Yu Chen, Alex Voss, 2006 .

Designing for e-Health: Recurring Scenarios in Developing Grid-based Medical Imaging Systems

Andrew C. Simpson, Nick C. Fox, Yu Chen, 2006, HealthGrid.

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 months

Peter Sandercock, Petr Svoboda, Phil Edwards, 2005, The Lancet.

Interpretation of the evidence for the efficacy and safety of statin therapy

Peter Sandercock, Bruce Neal, Liam Smeeth, 2016, The Lancet.

MRI Versus CT for Detection of Acute Vascular Lesions in Patients Presenting With Stroke Symptoms

Joanna M. Wardlaw, Peter Sandercock, Jonathan J Deeks, 2010 .

The NeuroGrid Stroke Exemplar Clinical Trial Protocol

Jeb Palmer, Peter Sandercock, David Perry, 2007, International journal of stroke : official journal of the International Stroke Society.

Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-Analysis of 55 Studies

Peter Sandercock, Joanna Wardlaw, P. Sandercock, 2012, Stroke.

A systematic review of barriers to delivery of thrombolysis for acute stroke.

Peter Sandercock, Joseph Kwan, P. Sandercock, 2004, Age and ageing.

The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

Peter Sandercock, Joanna Wardlaw, Stefano Ricci, 2008, Trials.

Systematic reviews of animal experiments

Peter Sandercock, Ian Roberts, P. Sandercock, 2002, The Lancet.

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Geoff Cohen, Peter Sandercock, Joanna M Wardlaw, 2012, The Lancet.

Stroke: Practical Management

Peter M. Rothwell, Joanna M. Wardlaw, Peter Sandercock, 2008 .

Project management plan

Kirsten Shuler, Peter Sandercock, Paul McNamee, 2014 .

Critical appraisal tools

Kirsten Shuler, Peter Sandercock, Paul McNamee, 2014 .

Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental Stroke

Peter Sandercock, Malcolm Macleod, Emily Sena, 2007, Stroke.

Evidence-based practice for stroke

Peter Sandercock, Peter Langhorne, P. Sandercock, 2009, The Lancet Neurology.

Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: study protocol for a randomized controlled trial

Peter Sandercock, P. Sandercock, M. Dennis, 2012, Trials.

Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial

Joanna M. Wardlaw, Eleni Sakka, Geoff Cohen, 2015, The Lancet Neurology.

Previous Use of Aspirin and Baseline Stroke Severity: An Analysis of 17 850 Patients in the International Stroke Trial

Peter Sandercock, Stefano Ricci, P. Sandercock, 2006, Stroke.

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Peter Sandercock, Joanna Wardlaw, G Middleton, 1997, The Lancet.

Blood Biomarkers in the Diagnosis of Ischemic Stroke: A Systematic Review

Peter Sandercock, William Whiteley, P. Sandercock, 2008, Stroke.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Geoff Cohen, Peter Sandercock, Stefano Ricci, 2012, The Lancet.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

Peter Sandercock, P. Sandercock, R. Holman, 2022 .

Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs

Joanna M. Wardlaw, Peter Sandercock, Joseph Kwan, 2004, Stroke.

In-Hospital Care Pathways for Stroke: An Updated Systematic Review

Peter Sandercock, Joseph Kwan, Graeme J. Hankey, 2005 .

DICTIONARY FOR CLINICAL TRIALS.

Peter Sandercock, 1999 .

Sensible approaches for reducing clinical trial costs

Peter Sandercock, Eric L Eisenstein, Robert M Califf, 2008, Clinical trials.

Trauma care research and the war on uncertainty

Peter Sandercock, Phil Edwards, Haleema Shakur, 2005, BMJ : British Medical Journal.

Follow-up by mail in clinical trials: does questionnaire length matter?

Peter Sandercock, Phil Edwards, P. Sandercock, 2004, Controlled clinical trials.